[乙型肝炎的当前治疗方法] - Suppr

Suppr

超能文献

[Current treatment of hepatitis B].

作者信息

Suárez García E, Romero Gómez M, Grande Santamaría L

机构信息

Sección de Aparato Digestivo, Hospital Universitarío de Valme, Sevilla.

出版信息

Gastroenterol Hepatol. 2001 Feb;24 Suppl 1:35-50.

PMID:11279893

Abstract

摘要

相似文献

[Current treatment of hepatitis B].

Gastroenterol Hepatol. 2001 Feb;24 Suppl 1:35-50.

Current limitations to nucleoside analogue therapy for chronic hepatitis B virus infection in the liver transplant and non-transplant settings.

J Gastroenterol Hepatol. 2000 Mar;15(3):227-9. doi: 10.1046/j.1440-1746.2000.02129.x.

[Hepatitis B (acute and chronic)].

Praxis (Bern 1994). 2004 Jul 28;93(31-32):1227-33; quiz 1234, 1261. doi: 10.1024/0369-8394.93.31.1227.

Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.

J Hepatol. 2005 Aug;43(2):200-2. doi: 10.1016/j.jhep.2005.05.011.

Nucleoside analogues for chronic hepatitis B.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1499-506. doi: 10.1097/00042737-200112000-00016.

[New antiviral agent. Hepatitis B therapy with slight resistance risk].

MMW Fortschr Med. 2003 Dec 18;145(51-52):40.

Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.

Antivir Chem Chemother. 2001 Jan;12(1):1-35. doi: 10.1177/095632020101200101.

Hepatitis B virus kinetics and mathematical modeling.

Semin Liver Dis. 2004;24 Suppl 1:11-6. doi: 10.1055/s-2004-828673.

Hepatitis B infection in China.

Clin Liver Dis. 2001 May;5(2):361-79. doi: 10.1016/s1089-3261(05)70170-7.

[The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].

Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):722-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Current treatment of hepatitis B].

Gastroenterol Hepatol. 2001 Feb;24 Suppl 1:35-50.

Current limitations to nucleoside analogue therapy for chronic hepatitis B virus infection in the liver transplant and non-transplant settings.

J Gastroenterol Hepatol. 2000 Mar;15(3):227-9. doi: 10.1046/j.1440-1746.2000.02129.x.

[Hepatitis B (acute and chronic)].

Praxis (Bern 1994). 2004 Jul 28;93(31-32):1227-33; quiz 1234, 1261. doi: 10.1024/0369-8394.93.31.1227.

Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.

J Hepatol. 2005 Aug;43(2):200-2. doi: 10.1016/j.jhep.2005.05.011.

Nucleoside analogues for chronic hepatitis B.

Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1499-506. doi: 10.1097/00042737-200112000-00016.

[New antiviral agent. Hepatitis B therapy with slight resistance risk].

MMW Fortschr Med. 2003 Dec 18;145(51-52):40.

Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.

Antivir Chem Chemother. 2001 Jan;12(1):1-35. doi: 10.1177/095632020101200101.

Hepatitis B virus kinetics and mathematical modeling.

Semin Liver Dis. 2004;24 Suppl 1:11-6. doi: 10.1055/s-2004-828673.

Hepatitis B infection in China.

Clin Liver Dis. 2001 May;5(2):361-79. doi: 10.1016/s1089-3261(05)70170-7.

[The efficacy of nucleoside/nucleotide analogue on chronic hepatitis B].

Zhonghua Gan Zang Bing Za Zhi. 2009 Oct;17(10):722-5.